Figure 10.

Sample throughput at the AMX and FMX beamlines. Total number of samples mounted at each of the two MX beamlines at the NSLS-II including samples from proprietary users. Sample throughput in calendar year 2020 is lower than expected due to the effect of the pandemic. Nevertheless, the AMX and FMX beamlines remained in operation to support ongoing efforts to deal with the pandemic including inhouse research on the main protease, the receptor binding domain of the spike protein and a peptide preventing fusion of the SARS-CoV-2 with the host cell membrane.